5 clinical trial advertising tips you can act on before 2024

Though there is less than a month remaining in 2023, there are still several things that can be done to improve an organization’s clinical trial marketing efforts before the end of the year. Not only will these tips help close the year out strong, but they can also set the stage for a more streamlined 2024 and beyond.

Continue reading

Patient perspectives: Meeting the wonderful “e-patient Dave”

At Antidote, matching individuals to clinical trials is our driving force — and one of the key ways we do this is by prioritizing our connection to patients. Understanding the real-world impact of our work allows us to continually improve our processes and approach clinical trial recruiting from a patient-centric perspective.

Continue reading

What is chronic spontaneous urticartia (chronic hives)?

Chronic spontaneous urticaria, also called chronic idiopathic urticaria, is a type of chronic hives that come and go unexpectedly. These hives persist daily for a minimum of six weeks without a clear cause or trigger. While this condition can affect anyone at any point, women experience it twice as often as men, and it’s most common between the ages of 20 and 40.

Continue reading

What to know about colon cancer stages

Despite the fact that colorectal cancer cases have been declining in the United States since the mid-1980s, it is still the third most common cancer diagnosed each year excluding skin cancer. Often shortened to colon cancer, colorectal cancer occurs when cells in the colon and/or the rectum begin to grow uncontrollably and eventually spread to other parts of the body.

Continue reading

IRT for clinical trials: Key features to look for

Interactive Response Technology (IRT) is an umbrella term that includes Interactive Web Response (IWRS) and Interactive Voice Response (IVRS) systems. These tools serve a critical role in ensuring clinical trials run smoothly, and as technologies develop, their capabilities only continue to expand.

Continue reading

What’s a corneal epithelial defect?

The cornea is the outermost layer of the human eye, serving both as a protective covering and allowing light into the retina. To perform this function, the cornea is made up of several layers, the outermost of which is known as the epithelium.

Continue reading

RTSM: Finding the right randomization & trial supply management system

One of the most crucial parts of running a clinical trial is managing randomization and drug supply levels. Ensuring that the right participants receive the right dosages of the right medication is essential to gathering accurate study results.

Continue reading

What motivates patients to participate in clinical trials? [Antidote 2023 survey data]

In both 2018 and 2023, Antidote partnered with SCORR marketing to conduct surveys intended to increase the understanding of patients’ perceptions of clinical trials. Our 2018 survey collected data from nearly 4,000 individuals to gain insight into what matters most when considering a clinical trial. Though smaller in scope, the 2023 survey had a similar goal of connecting with patients through ...

Continue reading

What is achondroplasia?

Achondroplasia, also known as achondroplastic dwarfism or ACH, is a rare disorder characterized by short stature, a large head, and short arms and legs. It is the most common type of skeletal dysplasia, the umbrella term that identifies hundreds of conditions, and occurs in about one in 15,000 to 35,000 births.

Continue reading

The evolution of clinical trial recruitment

As the medical research industry is ever-changing, so too is the continuous evolution of effective patient recruitment strategies. To gain more perspective on what these changes have looked like through the years, we chatted with Tom Ruane, the Global Head of Patient Recruitment at Parexel.

Continue reading

Get our latest posts in your inbox